Trump administration cancels plans to develop a bird flu vaccine

The Trump administration has canceled its contract with Moderna for developing an mRNA vaccine against bird flu viruses like H5N1, citing safety concerns and the unproven nature of mRNA technology. The decision reflects a shift in prioritizing safer vaccine platforms over emerging technologies that lack full testing. Experts have criticized this move, warning it could hinder preparedness for future pandemics by relying on less reliable technology.